Description of Side Effects of Cytotoxic Drugs in Cancaer Patient Undergoing Chemotherapy at Fatmawati General Hospital Jakarta in 2023
##plugins.themes.academic_pro.article.sidebar##
##plugins.themes.academic_pro.article.main##
Abstract
Cancer is a non-communicable disease which is characterized by uncontrolled cell division in the body. In 2022 in Indonesia, breast cancer will rank first at 16.2%, followed by lung cancer at 9.5%, then cervical cancer at 9%, colorectal cancer at 8.7%, liver cancer at 5.8%, and other cancers at 50.7%. One of the treatment methods in Patients suffering from cancer receive chemotherapy. Chemotherapy is a treatment using drugs that can inhibit or kill cancer cells which involves a combination of two or more drugs that are cytotoxic and can cause side effects in patients, which is usually called DRP (drug related problem). This research aims to find out the picture side effects of cytotoxic drugs in patients undergoing chemotherapy. This research was carried out using a descriptive retrospective method, using MESO pharmacist report data in the cancer center room and there were 38 patients who experienced side effects from cytostatic drugs. Of the 38 patients, the largest disease was ovarian cancer, 13 of them, the most frequently used therapy regimen was a combination of Paclitaxel and Carboplatin, 15, the most common side effect experienced by chemotherapy patients was dyspnea which occurred in 21 patients. And the antidote that is often used is Dexamethasone injection in 27 cases.
##plugins.themes.academic_pro.article.details##
References
2. Inernational Agency for Reaserch on Cancer. 2022. Factsheet. (https://gco.iarc.fr/today/en/fact-sheets-populations#countries), diakses 28 Februari 2024
3. Herdrich, K., Weinberger, 2010, Selected Schedules in the Therapy of Malignant Tumors, 15th Edition, Baxter Oncology
4. Shin Joosun, dkk. 2023. Distinct Shortness of Breath Profiles in Oncology Outpatients Undergoing Chemotherapy. Journal of pain and Symptom management vol 65. University of California, San Francisco
5. Aapro, M., & Alberts, D. (1981). High-dose dexamethasone for prevention of cis-platin-induced vomiting. Cancer Chemotherapy and Pharmacology, 7(1). doi:10.1007/bf00258206
6. Grunberg SM. Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis. Ann Oncol. 2007 Feb;18(2):233-40. doi: 10.1093/annonc/mdl347. Epub 2006 Nov 15. PMID: 17108149.
7. Agusweni dkk, 2020, Gambaran Faktor Risiko Insiden Kanker Ovarium Di RSUD Arifin Achmad Provinsi Riau, Jurnal Bers Indonesia.
8. Tsilidis, K., et al. (2011). Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. Diperoleh 15 Februari 2019 dari https://www.ncbi.nlm.nih.gov
9. M Segal, E., Bates, J., Fleszar, S. L., Holle, L. M., Kennerly-Shah, J., Rockey, M., & Jeffers, K. D. (2019). Demonstrating the value of the oncology pharmacist within the
healthcare team. Journal of Oncology Pharmacy Practice, 25(8), 1945–1967
10. Pangribowo, S. (2019). Beban Kanker di Indonesia [E-book]. Pusat Data dan Informasi Kementerian Kesehatan Republik Indonesia.
11. Boşnak, A. S., Birand, N., Diker, M., Abdi, A., & Başgut, B. (2018). The role of the pharmacist in the multidisciplinary approach to the prevention and resolution of drug-related problems in cancer chemotherapy. Journal of Oncology Pharmacy Practice, 25(6), 1312–1320.
12. Lexicomp. 2015. DRUG INFORMATION HANDBOOK with INTERNATIONAL TRADE NAMES INDEX. Americans Pharmacist Association